ProShare Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $923K | Sell |
|
|||||
|
2025
Q1 | $1.02M | Sell |
|
|||||
|
2024
Q4 | $1.13M | Buy |
|
|||||
|
2024
Q3 | $703K | Buy |
|
|||||
|
2024
Q2 | $440K | Sell |
|
|||||
|
2024
Q1 | $533K | Buy |
|
|||||
|
2023
Q4 | $462K | Buy |
|
|||||
|
2023
Q3 | $317K | Buy |
|
|||||
|
2023
Q2 | $570K | Buy |
|
|||||
|
2023
Q1 | $648K | Sell |
|
|||||
|
2022
Q4 | $572K | Buy |
|
|||||
|
2022
Q3 | $691K | Buy |
|
|||||
|
2022
Q2 | $539K | Sell |
|
|||||
|
2022
Q1 | $762K | Sell |
|
|||||
|
2021
Q4 | $1M | Buy |
|
|||||
|
2021
Q3 | $893K | Sell |
|
|||||
|
2021
Q2 | $1.3M | Buy |
|
|||||
|
2021
Q1 | $1.24M | Buy |
|
|||||
|
2020
Q4 | $1.48M | Buy |
|
|||||
|
2020
Q3 | $864K | Buy |
|
|||||
|
2020
Q2 | $936K | Buy |
|
|||||
|
2020
Q1 | $537K | Sell |
|
|||||
|
2019
Q4 | $1.03M | Sell |
|
|||||
|
2019
Q3 | $760K | Sell |
|
|||||
|
2019
Q2 | $1.01M | Sell |
|
|||||
|
2019
Q1 | $944K | Buy |
|
|||||
|
2018
Q4 | $750K | Sell |
|
|||||
|
2018
Q3 | $1.22M | Buy |
|
|||||
|
2018
Q2 | $860K | Buy |
|
|||||
|
2018
Q1 | $658K | Sell |
|
|||||
|
2017
Q4 | $472K | Buy |
|
|||||
|
2017
Q3 | $522K | Buy |
|
|||||
|
2017
Q2 | $442K | Buy |
|
|||||
|
2017
Q1 | $218K | Sell |
|
|||||
|
2016
Q4 | $306K | Buy |
|
|||||
|
2016
Q3 | $349K | Sell |
|
|||||
|
2016
Q2 | $208K | Buy |
|
|||||
|
2016
Q1 | $189K | Sell |
|
|||||
|
2015
Q4 | $1.05M | Buy |
|
|||||
|
2015
Q3 | $784K | Sell |
|
|||||
|
2015
Q2 | $1.51M | Sell |
|
|||||
|
2015
Q1 | $1.93M | Buy |
|
|||||
|
2014
Q4 | $1.42M | Buy |
|
|||||
|
2014
Q3 | $1.07M | Sell |
|
|||||
|
2014
Q2 | $760K | Sell |
|
|||||
|
2014
Q1 | $888K | Buy |
|
|||||
|
2013
Q4 | $198K | Buy |
|